MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BÜRGISSER, E.
Right arrow Articles by DE LEAN, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BÜRGISSER, E.
Right arrow Articles by DE LEAN, A.

Molecular Pharmacology, Vol 19, 205-216, Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics

Anomalous Equilibrium Binding Properties of High-Affinity Racemic Radioligands

ERNST BÜRGISSER 1, ARTHUR A. HANCOCK 1, ROBERT J. LEFKOWITZ 1, and ANDRE DE LEAN 1

1 Howard Hughes Medical Institute, Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina 27710

In receptor binding studies, high-affinity racemic radioligands are often used as tracers, neglecting the difference in affinity of their stereoisomers. We present an experimental and theoretical study comparing the binding of (±)-[3H]carazolol and (±)-[125I]hydroxy-benzylpindolol (HYP) to their pure respective isomers in the frog erythrocyte beta-adrenergic system. Saturation binding curves with the racemic radioligands showed deviations from a binding isotherm for a single ligand which were accentuated at higher receptor concentrations. When different affinity constants for both isomers were considered, significant improvement in the fits of the data were obtained by computer-modeling procedures. The KDav (average dissociation constant) obtained by considering the racemic radioligand as a single ligand, as has generally been done in the literature, varied with the receptor concentration from approximately 2 KD(-) at low receptor concentrations to cong0.5 KD(+) at high receptor concentrations. Thus the generally measured "KDav" of these racemic radioligands is really a hybrid of KD(-) and KD(+). These experimental findings are in very good agreement with Monte Carlo simulations and may help to explain the discrepancies in dissociation constants of high-affinity racemic radioligands reported in the literature. Experimental data and simulations also indicate that information about the KD(-) is greatest at low receptor concentrations, whereas that about KD(+) is greatest at high receptor concentrations. Simultaneous computer fitting of saturation curves from racemic [125I]HYP and the (+)-isomer, isolated by repeated incubations with frog erythrocyte membranes under appropriate conditions, indicates approximately a 20-fold ratio for the individual isomer KD values. Estimated KD values of the stereoisomers of [125I]HYP and [3H]carazolol were virtually identical, being KD(-) = 10-50 pM and KD(+) cong 400-2000 pM at 25°. Use of the KDav for a racemic radioligand resulted in up to 5-fold systematic underestimation of the affinity of nonracemic competitors. The KD values of all high-affinity competitors were also found to be misestimated by as much as 10-fold using the commonly employed Cheng and Prusoff [Biochem. Pharmacol. 22: 3099-3108 (1973)] approximation when the affinity of the radioligand was significantly lower than that of the competitor. Under such circumstances, slope factors of cong2 were obtained for competition curves in the absence of cooperativity.

Note:
ACKNOWLEDGMENTS A. D. L. wishes to thank Frank Starmer and Bruce Wright of the Department of Clinical Epidemiology, Duke University, for generously providing access and guidance to the PDP 11/45 computer. The authors also wish to thank Mrs. Elsie Priest and Mrs. Donna Addison for preparing the manuscript.

Submitted on August 27, 1980
Accepted on October 20, 1980




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
P. G. Strange
Antipsychotic Drugs: Importance of Dopamine Receptors for Mechanisms of Therapeutic Actions and Side Effects
Pharmacol. Rev., March 1, 2001; 53(1): 119 - 134.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics